Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:06:09.993Z.
Calculation as of: 2026-10-06T14:06:09.993Z.
Quote observation: 2026-10-06T14:05:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 273f4a35489c6dcba82bfbf6813c8f243fa8fa5e32baf23fc33ea9a1b57f5f97
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$173.89M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$179.31M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.88M
EV/EBIT Ratio
N/A
TTM Avg
50.33x
3Y Avg
50.33x
5Y Avg
50.33x
Market Cap
$165.46M
EV/EBIT Ratio
N/A
TTM Avg
8.53x
3Y Avg
141.14x
5Y Avg
141.14x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | $177.22M | N/A | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $178.56M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.89M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.65M | N/A | 8.18x | 8.18x | 8.18x |
| Canton Strategic Holdings Inc (CNTN)vs › | $179.31M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $182.88M | N/A | 50.33x | 50.33x | 50.33x |
| Coherus Oncology, Inc. (CHRS)vs › | $165.46M | N/A | 8.53x | 141.14x | 141.14x |
| AN2 Therapeutics, Inc. (ANTX)vs › | $191.97M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $159.74M | N/A | 189.93x | 95.49x | 94.46x |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.80M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
